(605507)"Guobang Pharma Ltd."Announcement on Progress in Repurchasing Shares
Filed with SSE · Stock code 605507 · · 2 pages · Chinese
Summary by 6ix AI
Guobang Pharma Ltd. has announced the progress of its share repurchase plan, detailing the number of shares repurchased and the total amount spent as of a specific date.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Story so far
Earlier from Guobang Pharma
- Announcement on Obtaining New Veterinary Drug Registration Certificate by Wholly-owned Subsidiary
- Announcement on a Wholly-owned Subsidiary's Product DMG-PEG2000 Passing the Joint Review and Approval with Its Formulation by the CDE
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Semi-annual Report for 2026
- Announcement on Progress in Repurchasing Shares
Later from Guobang Pharma
- (605507)"Guobang Pharma Ltd."Announcement on Change of Name and Other Industrial and Commercial Information of the Controlling Shareholder and Completion of Industrial and Commercial Registration Changes
- (605507)"Guobang Pharma Ltd."Announcement on Convening the Q3 2026 Performance Briefing
- (605507)"Guobang Pharma Ltd."Report for Q3 2026
- (605507)"Guobang Pharma Ltd."Announcement on Completion of Share Repurchase and Implementation Results of Repurchase
- (605507)"Guobang Pharma Ltd."Announcement on Share Repurchase Plan through Call Auction and the Repurchase Report
Follow Guobang Pharma into a list and get an email when it puts out news.
Follow Guobang Pharma